Abstract
This chapter will focus on the potential use of lipids and phospholipids as therapeutic agents in treating alcoholism, and on behavioral, biochemical and physiological interactions between alcohol, essential fatty acids, and prostaglandins. The rationale for these approaches is based on alcohol’s effects on membrane fluidity, lipid metabolism, and prostaglandin synthesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anton RF, Randall CL, Wallis CJ (1983) Effect of acute ethanol exposure on in vivo brain cortical PGE levels in C3H mice. Alcoholism 7: 104.
Bruni A and Toffano G (1982) Lysophosphatidylserine, a short-lived intermediate with plasma membrane regulatory properties. Pharmacol Res Commun 14: 469–482.
Cicero T (1978) Tolerance to and physical dependence on alcohol: behavioral and neurobiochemical mechanisms. In: Lipton MA, DiMascio A and Killam KF (eds): Psychopharmacology: A Generation of Progress. Raven Press, New York, pp. 1603–1615.
Crawford MA (1983) Background to essential fatty acids and their prostanoid derivatives, Br J Pharmacol 58: 9–16.
Ellingboe J (1978) Effects of alcohol on neurochemical processes. In: Lipton MA, DiMascio A and Killam KF (eds): Psychopharmacology: A Generation of Progress. Raven Press, New York, pp. 1653–1664.
George FR and Collins AC (1985) EthanoFs behavioral effects may be partly due to increases in brain prostaglandin production. Alcoholism, Clin Exp Res 9: 143–146.
George FR, Jackson SJ, Collins AC (1981) Prostaglandin synthesis inhibitors antagonize hypothermia induced by sedative hypnotics. Psychopharmacology 74: 241–244.
George FR, Elemer GI, Collins AC (1982) Indomethacin significantly reduces mortality due to acute ethanol exposure. Substance and Alcohol Actions/Misuse 3: 267–274.
Glen I (1984) Possible pharmacologic approaches to the prevention and treatment of alcohol related CNS impairment: results of a double blind trial of essential fatty acids. In: Edwards G and Littleton J (eds): Pharmacological Treatments for Alcoholism. Crooms-Helm, London, pp. 331–345.
Goheen SC, Larkin EC, Ananda Rao G (1983) Severe fatty liver in rats fed a fat-free ethanol diet and its prevention by small amounts of dietary arachidonate. Lipids 18: 285–289.
Hill M and Bangham AD (1975) General depressant drug therapy: a biophysical aspect. Adv Exp Med Biol 59: 1–10.
Karpe F, Neri A, Ånggård E (1983) The effect of dietary primrose oil on ethanol withdrawal in the rat. Acta Pharmacol Toxicol 53: 18P.
Littleton JM and John GR (1977) Synaptosomal membrane lipids of mice during continuous exposure to ethanol. J Pharm Pharmacol 29: 579–580.
Manku MS, Oka M, Horrobin DF (1979) Differential regulation of the formation of prostaglan-dins and related substances from arachidonic acid and dihomogammalinolenic acid. I. Effects of ethanol. Prostaglandins Med 3: 119–128.
Nervi AM, Peluffo RD, Brenner RR, Leikin AI (1980) Effect of ethanol administration on fatty acid desaturation. Lipids 15: 263–268.
Randall CL and Anton RF: Aspirin reduces alcohol-induced prenatal mortality and malformations in mice, submitted for publication.
Reitz RC (1980) The effects of ethanol administration on lipid metabolism. Lipids 15: 263–268.
Ritz MC, George FR, Collins AC (1981) Indomethacin antagonizes ethanol-induced but not pentobarbitol-induced behavioral activation. Substance and Alcohol Actions/Misuse 2: 289–299.
Rotrosen J, Mandio D, Segarnick D, Traficante LJ, Gershon S (1980) Ethanol and prostaglandin E1: biochemical and behavioral interactions. Life Sciences 26: 1867–1876.
Segarnick DJ, Rjer H, Rotrosen J (1985a) Precursor-and pool-dependent differential effects of ethanol on human platelet prostanoid synthesis. Biochem Pharmacol 34: 1343–1346.
Segarnick DJ, Mandio Cordasco D, Rotrosen J (1985b) Prostanoid modulation (mediation?) of certain behavioral effects of ethanol. Pharmacol Biochem Behav, 23:71–75.
Segarnick DJ, Mandio Cordasco D, Agura V, Cooper NS, Rotrosen J (1985c) Gamma linolenic acid inhibits the development of the ethanol-induced fatty liver. Prostaglandins Leukotrienes Med 17: 277–282.
Segarnick DJ, Wolkin A, Rotrosen J (1986) Biochemical, behavioral and clinical interactions between essential fatty acids, prostaglandins and ethanol. Advances in Lipid Research, in press.
Wilson DE, Engel J and Wong R (1973) Prostaglandin E1 prevents alcohol-induced fatty liver. Clinical Research 21:829.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rotrosen, J., Segarnick, D.J., Wolkin, A. (1986). Essential Fatty Acids and Phospholipids as Drugs in the Treatment of Alcoholism. In: Horrocks, L.A., Freysz, L., Toffano, G. (eds) Phospholipid Research and the Nervous System. FIDIA Research Series, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-0490-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0490-4_24
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4899-0492-8
Online ISBN: 978-1-4899-0490-4
eBook Packages: Springer Book Archive